Riskpilot← Back to searchSign inGet full accessDr. Segol N AB
ABIn liquidationOrg 5592305204FalunWholesale of pharmaceutical and medical goods · NACE 4646Est. 20190 employees
Revenue 2023
SEK 4,5M
-31% vs 2022
EBITDA margin
4.7%
-31% vs 2022
Equity ratio
51.6%
Financial strength
Net profit 2023
SEK 167K
-31% vs 2022
| Revenue | SEK 4,5M | -31% |
| EBITDA | SEK 212K | -31% |
| Net profit | SEK 167K | -31% |
| Total assets | SEK 2,1M | +6% |
| Equity | SEK 1,1M | +18% |
| Employees | 0 | — |
Legal name
Dr. Segol N AB
Org number
5592305204
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9 december 2019
Share capital
SEK 250 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn externa firmatecknarna
Company purpose
Bolaget ska bedriva partihandel med medicinsk utrustning och apoteksvaror samt bedriva därmed förenlig verksamhet.
Address
Falun
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenue | 3 568 | 7 833 | 6 455 | 4 461 |
| Staff expenses | — | — | — | −2 529 |
| EBITDA | 170 | 371 | 307 | 212 |
| Depreciation & amort. | −0 | −0 | −0 | — |
| EBIT | 170 | 371 | 307 | 212 |
| Net financials | — | — | — | 1 |
| Profit before tax | 170 | 371 | 308 | 212 |
| Tax | −38 | −79 | −66 | −45 |
| Net profit | 132 | 292 | 242 | 167 |
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Total assets | 1 552 | 1 820 | 1 980 | 2 099 |
| Equity | 382 | 674 | 916 | 1 083 |
| Long-term debt | 500 | 500 | 500 | 0 |
| Short-term debt | 670 | 646 | 565 | 1 015 |
| Total debt | 1 170 | 1 146 | 1 065 | 1 015 |
EBITDA margin
4.7%
This company
15.8%
Market median
-70% vs market
20202023
Equity ratio
51.6%
This company
38.2%
Market median
+35% vs market
20202023
Return on equity
15.4%
This company
18.4%
Market median
+16% vs market
20202023
Net profit margin
3.7%
This company
8.1%
Market median
-54% vs market
20202023
Asset turnover
2.13×
This company
1.12×
Market median
+90% vs market
20202023
Debt / equity
0.94×
This company
0.62×
Market median
+52% vs market
20202023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
LB External Signatory | External Signatory | 2024 |
IM External Signatory | External Signatory | 2024 |
BJ External Signatory | External Signatory | 2024 |
UM Liquidator | Liquidator | 2024 |
| Former (2) | ||
CO Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
BT | Audit | 2020 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Former (5) | ||
| Deputy Board Member | 2023 – 2023 | |
| Deputy Board Member | 2020 – 2022 | |
| Board of Directors | 2023 – 2023 | |
| Deputy Board Member | 2022 – 2024 | |
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 | |
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
WIMWAWO GMBH
Dr. Segol N AB (this company)Board members of Dr. Segol N AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Birgitta Killgren Jonsson | External Signatory | 0 companies |
| Inger Margareta Dahle | External Signatory | 0 companies |
| Carl Olov Olle Brolin | Chief Executive Officer | 0 companies |
| Bengt Junior Niklas Nygårds | External Signatory | 0 companies |
| Ulrika Margareta Ahlholm | Liquidator | 0 companies |
| Bengt Tomas Jerker Lundahl | Audit | 0 companies |
| Gregor Rudolf Loges | Deputy Board Member | 0 companies |
| Eva Margareta Eljans | Deputy Board Member | 0 companies |
| Carsten Karl Timmering | Board of Directors | 0 companies |
| Kord Bätge | Deputy Board Member | 0 companies |
| Anita Helena Berggren | Board of Directors | 0 companies |